Table 6 HCV infection clinical management prior and after exposure to HEP
Endpoint | Baseline % (n/N) | Post-HEP % (n/N) | p value |
|---|---|---|---|
Patient referral rate | 56.2 % (283/504) | 67.5 % (340/504) | <0.001 |
95 % CI | 51.8–60.5 % | 63.4–71.6 % | |
Attendance at referral rate | 74.4 % (203/273) | 73.5 % (250/340) | 0.904 |
95 % CI | 69.2–79.5 % | 68.8–78.2 % | |
Treatment proposal rate | 60.1 % (122/203) | 52.0 % (130/250) | <0.001 |
95 % CI | 53.4–66.8 % | 45.8–58.2 % | |
Treatment initiation rate | 47.5 % (58/122) | 57.7 % (75/130) | 0.114 |
95 % CI | 38.7–56.4 % | 49.2–66.2 % | |
Treatment retention rate | 75.9 % (44/58) | 76.0 % (57/75) | 0.108 |
95 % CI | 64.8–86.9 % | 65.2–84.3 % |